Sometimes Smaller is Better
Jun 10, 2020
2 minutes Read
General
There are massive tangible advantages of working together with a boutique CRO as opposed to the “big guys”. Boutique CRO’s have a distinct advantage of attentiveness, adaptability, speed and quality. In the scientific research industry where quality of data is paramount, paying attention is critical.
It is time to separate the BEST from the biggest; By not being the giants of the nonclinical CRO space, boutique CROs such as Attentive Science are attentive to you and your mission. Industry veterans are able to respond to you with speed and accuracy. A simple differentiation of a boutique CRO is evident in responding to your request for a quotation for a specific study type. A boutique CRO will respond to you within 2 days, whilst the “big guys” may take 2 weeks. It is inherent in the structure of the “big guys” to have multiple layers of review and red tape, thus clogging their own wheel.
When and why it is advantageous to go with boutique rather than the “big guys”
Your sophisticated research requires specialized services, which is why you should work with a boutique CRO. If you have been told that you are, and/or treated like the small fish, boutique CROs such as Attentive Science will work together with you to ensure you remain special, simply because you are special. We are all unique, and you should not let anyone convince you otherwise. You don’t have to imagine anymore what it will feel like to be special and not be crumped up in the “big guys” queue and its bureaucracy. Attentive Science pays more attention to you, your company and its mission.
Want to know more? Contact Us or Let us know using the form below and we will contact you to set up a time to discuss!
Social Networks
Tags
Related Blogs
Lab Technicians: The Unsung Heroes Driving Research Success
At Attentive Science, our laboratory technicians are more than technical experts; they are collaborators and real-time problem-solvers
2 mins read
Feb 5, 2026
The Future of CROs: Not AI vs Humans, But AI With Humans.
As 2025 closed, one question dominated life sciences: Will artificial intelligence (AI) replace humans in drug development?
3 mins read
Jan 12, 2026
News Flash: Dr. Basel Assaf Joins Attentive Science Limited
Attentive Science is proud to welcome Dr. Basel Assaf, BVSc, PhD, DACVP, DABT, FIATP as our new Vice President of Toxicology and Pathology.
2 mins read
Sep 24, 2025
Attentive Science Welcomes Thomas O'Neill
We are thrilled to welcome Thomas O’Neill to Attentive Science as our Executive Vice President of Commercial Services and Client Relations.
2 mins read
Mar 11, 2025